Queerty on MSN13d
More good news about the twice-yearly PrEP injection
More encouraging news has been announced about the new, twice-yearly PrEP injection currently undergoing trials. Lenacapavir ...
AllAfrica.com15d
Africa: Advances in PrEP Options and HIV Vaccine Research Unveiled at HIVR4P 2024, the 5th HIV Research for Prevention Conference
“These findings confirm that lenacapavir for PrEP has the potential to transform ... for signing voluntary licensing agreements with generic manufacturers to increase access to lenacapavir ...
news.scienceafrica18d
Injectable PrEP: Generic Versions to Benefit 120 Countries
To increase access to injectable lenacapavir pre-exposure prophylaxis (PrEP), Gilead Sciences, an American biopharmaceutical company, has signed licensing agreements with six generic medicine ...
Nasdaq18d
GILD Grants Right for HIV PrEP Candidate to Six Generic Companies
However, this will take time. Therefore, until generic versions are available, Gilead will supply lenacapavir directly and is focusing on registering the candidate in 18 countries that account for ...
Yahoo Finance18d
GILD Grants Right for HIV PrEP Candidate to Six Generic Companies
Gilead Sciences GILD has entered into licensing deals with six pharmaceutical companies to manufacture and supply a cheaper version of its investigational drug, lenacapavir, for HIV prevention, also ...
Inside Higher Ed19d
Employers Say Students Need AI Skills. What If Students Don’t Want Them?
A May 2024 survey by Inside Higher Ed and Generation Lab asked students if they knew when, how or whether to use generative artificial intelligence to help with coursework. Student responses revealed ...